Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas

Authors: Perlow, Haley K. ^a, Raleigh, David R. ^b, Wang, Tony J.C. ^c, Pollom, Erqi L. ^d, Milano, Michael T. ^e, Breen, William G. ^f, Detsky, Jay ^g, Chang, Eric L. ^h, Tom, Martin C. ⁱ, Shiue, Kevin R. ^j, Lehrer, Eric J. ^f, Saeed, Hina ^k, Pike, Luke R.G. ^l, Lo, Simon S. ^m, Mishra, Mark V. ⁿ, Knisely, Jonathan P.S. ^o, Chao, Samuel T. ^p, Sahgal, Arjun ^g, Palmer, Joshua D. ^{q, ⁎}

Source: In International Journal of Radiation Oncology, Biology, Physics 1 May 2025 122(1):150-158

Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery

Authors: Ma, Jennifer ^{a, †}, del Balzo, Luke ^{a, b, †}, Walch, Henry ^{c, †}, Khaleel, Sari ^d, Knezevic, Andrea ^c, Flynn, Jessica ^c, Zhang, Zhigang ^c, Eichholz, Jordan ^e, Doshi, Sahil D. ^d, Voss, Martin H. ^d, Freeman, Benjamin ^f, Ari Hakimi, A. ^f, Lee, Chung-Han ^d, Bale, Tejus A. ^g, Kelly, Daniel ^h, Mueller, Boris A. ^a, Mann, Justin ^a, Yu, Yao ^a, Zinovoy, Melissa ^a, Chen, Linda ^a, Cuaron, John ^a, Khan, Atif ^a, Yamada, Yoshiya ^a, Shin, Jacob Y. ^a, Beal, Kathryn ^a, Moss, Nelson S. ⁱ, Carlo, Maria I. ^d, Motzer, Robert J. ^d, Imber, Brandon S. ^a, Kotecha, Ritesh R. ^{d, †}, Pike, Luke R.G. ^{a, †, ⁎}

Source: In European Urology Oncology April 2025 8(2):338-346

Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery

Authors: Gaeta, Benjamin ^{a, b}, Eichholz, Jordan E. ^c, Walch, Henry ^{c, d}, Ilica, Ahmet T. ^e, Boe, Lillian ^d, Kratochvil, Leah ^f, Yu, Yao ^a, Gomez, Daniel R. ^{a, g}, Imber, Brandon S. ^a, Li, Bob T. ^{f, h}, Murciano-Goroff, Yonina R. ^{f, h}, Arbour, Kathryn C. ^h, Schultz, Nikolaus ^d, Lebow, Emily S. ^{a, g, i}, Pike, Luke R.G. ^{a, g, ⁎}

Source: In International Journal of Radiation Oncology, Biology, Physics January 2025

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

Authors: Liu, Si-Yang, Erazo, Tatiana, Jee, Justin, Arfe, Andrea, Gupta, Avantika, Pike, Luke R.G., Santini, Fernando C., Daly, Bobby, Schoenfeld, Adam, Eichholz, Jordan, Johnson, Kaylie, Martinez, Andres, Sui, Jane, Riaz, Nadeem, Chang, Jason, Yang, Soo-Ryum, Travis, William, Arcila, Maria E., Guo, Jiannan, Gagne, Eric, Garg, Kavita, Baehner, Frederick, Lee, Nancy Y., Drilon, Alexander, Kris, Mark G., Scher, Howard I., Razavi, Pedram, Gomez, Daniel R., Jones, David R., Rudin, Charles M., Chandarlapaty, Sarat, Isbell, James M., Li, Bob T.

Source: In European Journal of Cancer October 2024 210

Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC

Authors: Imber, Brandon S., Sehgal, Ryka, Saganty, Rachel, Reiner, Anne S., Ilica, A. Turan, Miao, Emily, Li, Bob T., Riely, Gregory J., Yu, Helena A., Panageas, Katherine S., Young, Robert J., Pike, Luke R.G., Moss, Nelson S.

Source: In JTO Clinical and Research Reports December 2023 4(12)

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

Authors: Miao, Emily, Eichholz, Jordan E., Lebow, Emily S., Flynn, Jessica, Zhang, Zhigang, Walch, Henry, Hubbeling, Harper, Beal, Kathryn, Moss, Nelson S., Yu, Kenny K., Meng, Alicia, Kelly, Daniel W., Gomez, Daniel R., Li, Bob T., Rimner, Andreas, Schultz, Nikolaus, Drilon, Alexander, Imber, Brandon S., Pike, Luke R.G.

Source: In Lung Cancer April 2023 178:57-65

Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation

Authors: Imber, Brandon S., O'Dwyer, Elisabeth, Lobaugh, Stephanie, McBride, Sean M., Hopkins, Margaret, Kollmeier, Marisa, Gorovets, Daniel, Brennan, Victoria, Pike, Luke R.G., Gewanter, Richard, Mychalczak, Borys, Zhang, Zhigang, Schöder, Heiko, Zelefsky, Michael J.

Source: In Urology December 2022 170:146-153

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors

Authors: Qian, Jack M., Akama-Garren, Elliot, Shin, Jungwook, Gunasti, Lauren, Bang, Andrew, Pike, Luke R.G., Grassberger, Clemens, Schoenfeld, Jonathan D.

Source: In Advances in Radiation Oncology March-April 2022 7(2)

Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases.

Authors: Tringale, Kathryn R., Skakodub, Anna, Egger, Jacklynn, Eichholz, Jordan, Yu, Yao, Gomez, Daniel, Rimner, Andreas, Li, Bob, Yamada, Yoshiya, Wilcox, Jessica, Moss, Nelson, Imber, Brandon S., Rekhtman, Natasha, Baine, Marina K., Rudin, Charles M., Pike, Luke R.G.

Source: JCO Precision Oncology; 12/1/2024, Vol. 8, p1-11, 11p

Subject Terms: SMALL cell lung cancer, PROPORTIONAL hazards models, TRANSCRIPTION factors, OVERALL survival, PROGRESSION-free survival

A balancing ACT: maximizing the benefits of appropriate brain radiation therapy

Authors: Yerramilli, Divya ^∗, Pike, Luke R.G., Janopaul-Naylor, James

Source: In The Lancet Regional Health - Europe May 2025 52

Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate Therapy

Authors: Lebow, Emily S. ^{a, b}, Eichholz, Jordan ^c, Zhang, Zhigang ^c, Toumbacaris, Nicolas ^c, Imber, Brandon ^a, Chen, Linda ^a, LaPlant, Quincey ^a, Yamada, Josh ^a, Pike, Luke R.G. ^a, Modi, Shanu ^d, Seidman, Andrew D. ^d, Beal, Kathryn ^e, Moss, Nelson S. ^f, Yu, Yao ^{a, ⁎}

Source: In Advances in Radiation Oncology March 2025 10(3)

Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+ OPC

Authors: Sanford, Nina N., Hwang, William L., Pike, Luke R.G., Lam, Allen C., Royce, Trevor J., Mahal, Brandon A.

Source: In Oral Oncology November 2019 98:28-34

Sex Disparity and Copy Number Alterations in Esophageal Squamous Cell Carcinoma

Authors: Sanford, Nina N., Mahal, Brandon A., Royce, Trevor J., Pike, Luke R.G., Hwang, William L.

Source: In Clinical Gastroenterology and Hepatology May 2019 17(6):1207-1209

Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy

Authors: Pike, Luke R.G., Wu, Jing, Chen, Ming-Hui, Loffredo, Marian, Renshaw, Andrew A., Pfail, John, Kantoff, Philip W., D'Amico, Anthony V.

Source: In Urology April 2019 126:145-151

Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC).

Authors: Pike, Luke R.G., Miao, Emily, Boe, Lillian A., Patil, Tejas, Imber, Brandon S., Myall, Nathaniel J., Pollom, Erqi L., Hui, Caressa, Qu, Vera, Langston, Jacob, Chiang, Veronica, Grant, Michael, Goldberg, Sarah B., Palmer, Joshua D., Prasad, Rahul N., Wang, Tony J.C., Lee, Albert, Shu, Catherine A., Chen, Lanyi Nora, Thomas, Nicholas J.

Source: Journal of Clinical Oncology; 10/20/2024, Vol. 42 Issue 30, p3606-3617, 20p

HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx

Authors: Pike, Luke R.G., Hwang, William L., Royce, Trevor J., Sanford, Nina N., Mahal, Brandon A.

Source: In Oral Oncology November 2018 86:69-74

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation

Authors: Pike, Luke R.G., Bang, Andrew, Ott, Patrick, Balboni, Tracy, Taylor, Allison, Catalano, Paul, Rawal, Bhupendra, Spektor, Alexander, Krishnan, Monica, Cagney, Daniel, Alexander, Brian, Aizer, Ayal A, Buchbinder, Elizabeth, Awad, Mark, Gandhi, Leena, Hodi, F. Stephen, Schoenfeld, Jonathan D

Source: In Radiotherapy and Oncology July 2017 124(1):98-103

Improved CNS Control With the Addition of Chemotherapy to Osimertinib: A Devil's Bargain?

Authors: Yu, Yao, Miao, Emily, Pike, Luke R.G.

Source: Journal of Clinical Oncology; 6/10/2024, Vol. 42 Issue 17, p2107-2108, 3p

Author Reply

Authors: Pike, Luke R.G., D'Amico, Anthony V.

Source: In Urology April 2019 126:151-151

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.

Authors: Pike, Luke R.G.^1,2 lrpike@partners.org, Bang, Andrew^1,3, Mahal, Brandon A.^1,2, Taylor, Allison¹, Krishnan, Monica¹, Spektor, Alexander¹, Cagney, Daniel N.¹, Aizer, Ayal A.¹, Alexander, Brian M.¹, Rahma, Osama¹, Balboni, Tracy¹, Ott, Patrick A.¹, Hodi, F. Stephen¹, Schoenfeld, Jonathan D.¹

Source: International Journal of Radiation Oncology, Biology, Physics. Jan2019, Vol. 103 Issue 1, p142-151. 10p.

Subject Terms: *RADIOTHERAPY, *LYMPHOCYTES, *IMMUNE response, *LYMPHOPENIA, *NON-small-cell lung carcinoma, *MELANOMA, *CELL death